Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

After Dobbs, States Become Battleground For Abortion Rights No Photo Available

Marco Poggio

Three years ago, when the U.S. Supreme Court overturned the precedent set by Roe v. Wade, it did more than end nearly five decades of ... (more story)

Under The Radar: Bankruptcy News You May Have Missed No Photo Available

Emlyn Cameron

The U.S. Trustee's Office opposed Prospect Medical's Chapter 11 plan disclosure on the grounds that the plan can't be confirmed becaus... (more story)

Healthcare Deals This Week: Sanofi, Abridge, Royalty Pharma No Photo Available

Yeji Jesse Lee

The past week marked a busy period for dealmaking in the healthcare industry, with major partnerships and M&A announcements from compa... (more story)